PSA-selective activation of cytotoxic human serine proteases within the tumor microenvironment as a therapeutic strategy to target prostate cancer

Prostate cancer is the most diagnosed malignancy and the second leading cause of cancer-related death in American men. While localized therapy is highly curative, treatments for metastatic prostate cancer are largely palliative. Thus, new innovative therapies are needed to target metastatic tumors....

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, Oliver C., Anthony, Lizamma, Rosen, D. Marc, Brennen, W. Nathaniel, Denmeade, Samuel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976476/
https://www.ncbi.nlm.nih.gov/pubmed/29854290
http://dx.doi.org/10.18632/oncotarget.25091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976476/
https://www.ncbi.nlm.nih.gov/pubmed/29854290
http://dx.doi.org/10.18632/oncotarget.25091

Ejemplares similares